大中华地产控股(00021.HK)拟折让20%配售不超6.63亿股净筹7630万港元
格隆汇7月19日丨大中华地产控股(00021.HK)宣布,于2019年7月19日,公司拟向不少于六名投资者配售最多6.63亿股新股,占经扩大后公司股份16.67%,每股配售价0.12港元,较7月19日收市价0.15港元折让约20%。
假设全部配售股份获悉数配售,配售事项之所得款项总额将约为7950万港元。经扣除配售事项所附带之所有相关开支后,配售事项之所得款项净额估计将约为7630万港元。配售事项的所得款项净额拟用作一般营运资金、于适当机遇出现时用于集团的任何可能业务发展及投资,以及用于结清股东贷款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.